NCT01778569View on ClinicalTrials.gov

The Psoriasis, Atherosclerosis, and Cardiometabolic Disease Initiative (PACI)

CompletedOBSERVATIONAL
Enrollment

386

Participants

Timeline

Start Date

January 22, 2013

Primary Completion Date

January 6, 2023

Conditions
Metabolic DiseaseCardiovascular DiseaseInflammationPsoriasis
Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT01778569 - The Psoriasis, Atherosclerosis, and Cardiometabolic Disease Initiative (PACI) | Biotech Hunter | Biotech Hunter